0:00
/
0:00
Transcript

How to appraise the control arm in oncology trials, in 10 minutes!

From a recent virtual session I had the pleasure of giving at IOSI, Ticino, Switzerland.

On 26 March 2025, I had the pleasure and honor of being kindly invited by Professor Silke Gillessen, Head of the Oncology Institute of Southern Switzerland (IOSI) at the Ente Ospedaliero Cantonale (EOC), to deliver a lecture entitled: “Step-by-Step: How I Appraise Clinical Oncology Publications.”

Here is an excerpt on evaluating the control arm in oncology randomized clinical trials – a key element in judging trial validity and relevance.

The Drug Development Letter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.